CORC

浏览/检索结果: 共3条,第1-3条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries 会议论文
作者:  Sun, Guo-ping;  Sun, Yan;  Xu, Rui-hua;  Xu, Jian-Ming;  Li, Jin
收藏  |  浏览/下载:6/0  |  提交时间:2019/12/19
A phase II, multicenter, open-label, single-arm trial of famitinib in patients with advanced recurrent and/or metastatic nasopharyngeal carcinoma (NPC) after two previous treatment regimens 会议论文
作者:  Huang, Yan;  Zhang, Li;  Pan, Jian-ji;  Hu, Guoqing;  Gang, Wu
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
The Chinese subgroup from a randomized phase III study of lapatinib in combination with weekly paclitaxel versus weekly paclitaxel alone as second-line treatment of HER2-amplified advanced gastric cancer (AGC) in Asian countries 会议论文
JOURNAL OF CLINICAL ONCOLOGY, 2013-05-20
作者:  Sun, Guo-ping;  Sun, Yan;  Xu, Rui-hua;  Xu, Jian-Ming;  Li, Jin
收藏  |  浏览/下载:5/0  |  提交时间:2020/01/13


©版权所有 ©2017 CSpace - Powered by CSpace